Cheryl Cohen
CIK 1529371 · Chief Commercial Officer · last filed 2026-10-06
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Charts
Trading activity, where the exposure sits, and each trade against the stock price.
MDVN price and trades
Daily close with each Form 4 filing on this company marked: green = open-market buy, red = open-market sale, purple = grants, exercises, gifts and other non-market transactions. Marker size scales with the dollar value.
Shares held
Shares owned after each reported transaction on this company (direct holdings as reported).
Open-market buying and selling
by monthDollar value of open-market purchases (code P, up) and sales (code S, down) across all companies, by filing month. Grants, exercises and gifts are excluded.
Exposure by company
latestMost recently reported shares × current price. Faded bars (*) have had no filing in 3 years, so the person may no longer hold them. Click a bar to chart that company.
Filer Profile
53 FRONTAGE ROAD, SUITE 220
HAMPTON, NJ 08827
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| IBRX | Director | 181,365 | $8.65 | $1.57M | -$2.81M | 10 | 2026-10-06 |
| CLDX | Director | — | $30.72 | — | $0 | 5 | 2026-06-29 |
| Lite Strategy, Inc. (MEIP) Delisted | Director | — | $3.20 | — | $0 | 4 | 2022-07-07 |
| Whitehawk Therapeutics, Inc. (ARPO) Delisted | Director | 1,077 | $33.00 | $35.5K | $0 | 6 | 2021-07-02 |
| ImmunityBio, Inc. (NK) Delisted | Director | 270,925 | — | — | -$298.8K | 3 | 2020-08-13 |
| Eledon Pharmaceuticals, Inc. (NVUS) Delisted | Director | — | — | — | $0 | 3 | 2019-07-15 |
| Eledon Pharmaceuticals, Inc. (TKAI) Delisted | Director | — | — | — | $0 | 2 | 2016-06-16 |
| LadRx Corp (CYTXW) Delisted | Director | — | — | — | $0 | 1 | 2015-12-17 |
| MEDIVATION, INC. (MDVN) Delisted | Chief Commercial Officer | 64,872 | — | — | -$6.05M | 11 | 2014-02-20 |
Recent Filings · Page 5 of 6
54 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2015-10-27 | — | Buy (P) | +3,500 | $25.1K | |
| 2015-07-15 | — | Grant (A) | — | $0 | |
| 2015-04-13 | Eledon Pharmaceuticals, Inc. (TKAI) Delisted | Grant (A) | — | $0 | EDGAR |
| 2014-02-20 | MEDIVATION, INC. (MDVN) Delisted | Grant (A) | — | $0 | EDGAR |
| 2014-02-06 | MEDIVATION, INC. (MDVN) Delisted | Grant (A) | +7,000 | $0 | EDGAR |
| 2013-10-28 | MEDIVATION, INC. (MDVN) Delisted | Mixed | — | -$2.73M | EDGAR |
| 2013-08-06 | MEDIVATION, INC. (MDVN) Delisted | Mixed | — | -$1.24M | EDGAR |
| 2013-07-08 | MEDIVATION, INC. (MDVN) Delisted | Mixed | — | -$1.11M | EDGAR |
| 2012-12-18 | MEDIVATION, INC. (MDVN) Delisted | Grant (A) | — | $0 | EDGAR |
| 2012-12-11 | MEDIVATION, INC. (MDVN) Delisted | Grant (A) | +9,000 | $0 | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.